(Total Views: 112)
Posted On: 08/07/2019 8:40:42 AM
Post# of 85481

$ATNX News Article - Athenex Announces Oral Paclitaxel and Encequidar had a Significantly Higher Response Rate Over IV Paclitaxel in a Phase III Pivotal Study in Metastatic Breast Cancer https://marketwirenews.com/news-releases/athe...74105.html


My Twitter: WhyteStocks